← All companies

GenEdit

Healthcare & Life Sci

Company overview

BreezeBio develops genetic medicines that deliver treatment directly to specific cells and tissues, with a focus on autoimmune diseases. NanoGalaxy is its programmable platform for delivering genetic payloads. Its lead program, BRZ-101, is a therapy for Type 1 Diabetes designed to induce immune tolerance.

BreezeBio was co-founded by Kunwoo (Ryan) Lee, Hyo Min (Huey) Park, and Niren Murthy. Its investors include Eli Lilly and Sequoia. GenEdit is an H-1B sponsor.

Industry
Healthcare & Life Sci
Headquarters
Brisbane, United States

Filters

Create your account

Create an account to save jobs and track applications.